Poolbeg Pharma PLC (POLB.L)
GBp 3.05
(-6.15%)
GBp 3.05
(-6.15%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -5.03 Million GBP | -1.06% |
| 2022 | -4.98 Million GBP | -113.44% |
| 2021 | -2.33 Million GBP | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1264.50 GBP | 0.0% |
| 2024 Q1 | -1264.50 GBP | 99.95% |
| 2023 Q3 | -1478.00 GBP | 99.93% |
| 2023 FY | -5.04 Million GBP | -1.12% |
| 2023 Q1 | -1041.50 GBP | 99.97% |
| 2023 Q2 | -2.26 Million GBP | -216894.72% |
| 2023 Q4 | -2.79 Million GBP | -188871.58% |
| 2022 Q2 | -1.88 Million GBP | -215082.65% |
| 2022 FY | -4.98 Million GBP | -113.44% |
| 2022 Q4 | -3.37 Million GBP | -192325.97% |
| 2022 Q3 | -1756.00 GBP | 99.91% |
| 2022 Q1 | -876.00 GBP | 0.0% |
| 2021 FY | -2.33 Million GBP | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|